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Transferrin mRNA content and gene transcription rate were measured inthe liver of rats submitted to iron 
overload or depletion, castration, treatment with sexual steroid hormones, glucagon and cyclic AMP. The 
influence of puberty in males and females and of pregnancy was also analysed. Glucagon and cyclic AMP 
reduced mRNA level by about 50% at the 12th hour of treatment and transferrin gene transcription by 
as much as 95% at the 30th minute of drug infusion, with a secondary increase of the transcription rate 
for a protracted treatment. None of the other hormones tested had any detectable ffect on transferrin gene 
expression, the same being true for iron overload or depletion. 
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1. INTRODUCTION 
Cyclic AMP (CAMP) has recently been proved 
to be able to transcriptionally inhibit the expres- 
sion of several genes encoding carbohydrate- 
stimulated liver enzymes [1,2] and is known since 
1982 to be a transcriptional activator of other 
genes, especially liver genes whose expression is 
repressed by carbohydrates and insulin [3,4]. 
We show in this paper that the transferrin gene, 
encoding serotransferrin, the main iron-binding 
protein in serum, is itself modulated by CAMP: 
transcription of the gene is profoundly but tran- 
siently inhibited by both CAMP and glucagon, 
while other agents which were expected to regulate 
transferrin gene expression (iron and sexual steroid 
hormones) proved to be without any detectable in- 
fluence on the gene transcription. 
2. MATERIALS AND METHODS 
2.1. Animals 
The following adult animals weighing 200-250 g 
were used: (i) 6 male Wistar rats were made 
anaemic by cardiac puncture, 1 ml twice a week, 
and by feeding an iron-deficient diet (gruyere 
cheese and egg white). Rats were killed after 5, 7, 
8, 9 and 10 cardiac punctures. Hyposideraemia 
was profound from the 5th puncture (serum iron 
concentration < 5 PM, normal range 40 f 5 pM). 
Serum transferrin level was measured by the iron 
capacity saturation which was > 160~M (normal 
range 106 + 20pM). (ii) Iron overload was pro- 
duced in 18 Sprague Dawley male rats over a 
3-month period by using the method of Bacon et 
al. [5] slightly modified as follows: in our protocol, 
rats weighing initially 200 g were fed a diet sup- 
plemented with 5% carbonyl iron. This model pro- 
duces a pathological pattern of iron overload 
similar to human haemochromatosis (marked 
hepatocellular iron overload with a periportal 
distribution). (iii) 24 Sprague Dawley rats (12 
males, 12 females) were castrated. 9 females were 
given 20 pg oestradiol in a single intradermal injec- 
tion [6,7]; 3 of them were killed 2, 5 and 12 h after 
hormone injection. Oestrogen effect on ovariec- 
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tomized rats was assessed by weighing the uterus 
and measurement of uterine progesterone recep- 
tors [8]. In all cases oestrogen treatment caused an 
increase in uterine weight and in the number of 
uterine receptors showing that the treatment was 
effective [8]. The same procedure was repeated 
with 9 castrated male rats injected with 1 mg 
testosterone. 3 castrated rats of each sex were 
killed before any hormonal treatment. 
The influence of glucagon and CAMP was 
studied in Wistar rats exactly as published [l]. 
A rat transferrin cDNA probe about 1400 bp 
long was used in this study [9,10]. The methods of 
RNA purification, Northern and dot blot analysis 
have been described [ l,lO, 111. 
2.2. Run-on transcription on isolated nuclei 
Transcription by isolated nuclei and subsequent 
isolation of 32P-labeled RNA were performed as 
described [2]. Briefly, nuclei were isolated from 
rats submitted to the studied metabolic conditions 
and the RNA polymerase bound on the gene at the 
moment of killing allowed to continue RNA syn- 
thesis in the presence of radioactive precursors. 
The reaction was terminated by the addition of 
DNase I made RNase-free by a 2-h treatment at 
37°C with proteinase K in the presence of CaClz 
[ 121. The radioactively labeled nuclear RNAs were 
purified by ethanol precipitation in guanidine-HCl 
in the presence of carrier poly(A-)-RNA from rab- 
bit muscle, then hybridized to transferrin cDNA 
sequences immobilized on ‘gene screen plus’ nylon 
filters: this type of nylon membrane allows multi- 
ple use of the specific filters without decrease of 
the specific signal (unpublished). 
After extensive washing and digestion with pan- 
creatic RNase, the fraction of the total radioactive 
transcripts derived from the exonic transferrin 
gene sequence which hybridizes with cDNA probe 
was measured by liquid scintillation counting. 
Results are expressed in parts per million of 
radiolabeled RNA (ppm). 
Rate of transferrin mRNA synthesis (in ppm) = 
specific cpm eluted from the filters/total cpm of 
radiolabeled RNA x (lOO/efficiency) x the length 
of transferrin gene/the length of the transferrin 
cDNA insert in base pairs. The length of the 
transferrin gene has been recently estimated to be 
about 30 kb [ 131. To estimate the hybridization ef- 
ficiency, [3H]cRNA was prepared according to Lis 
et al. [14] using the purified 1400 bp cDNA insert: 
hybridization efficiency was on average 40%. 
Typically, 25-40 x lo6 cpm of labeled RNA 
were obtained from each reaction. Background 
hybridizations to a pBR322 filter were less than 
20 ppm. 
The DNA of a recombinant plasmid containing 
sequences complementary to mRNA for the 
albumin protein was included as an internal stan- 
dard in the hybridization experiment. The length 
of the albumin gene is 15 kb and the cDNA insert 
is 1000 bp 1151. 
Fig.1. Influence of iron on liver transferrin mRNA 
content. For measuring specific mRNA concentration by 
dot blot analysis, 10 pg and 5 subsequent 1: 2 dilutions 
of total RNA (and poly A+ mRNA for control) were 
dotted onto nitrocellulose filters, the hybridization being 
performed in the presence of 2 x lo6 cpm/ml of labeled 
purified inserts (0.5 ml of hybridization mixture per 
10 cm” of filter surface). The radioactivity was a linear 
function of the RNA amounts deposited on the filters. 
The results are expressed in cpm of radiolabeled probe 
per ,ug of RNA. All the individual experiments included 
a standard range consisting of the aliquoted dilutions of 
the same normal liver RNA preparation. In preliminary 
hybridization experiments transferrin mRNA of this 
standard preparation was measured to 2200 cpm/pg 
RNA. All the results were normalized with respect o this 
value. (A) Iron deficiency induced by heart punctures. 
Each point represents the result of one individual 
measurement. (B) Iron overload. Each point represents 
the mean f 1 SD of 6 determinations in each of 3 rats. 
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Table 1 
Effects of castration, oestrogen administration and iron 
status on transferrin gene transcription 
Hormonal status 
None 
Castration (male) 
Castration (female) 
Oestradiol ad- 
Transferrin Albumin 
gene gene 
transcription transcription 
811 f 49 1208 f 233 
771 1155 
772 1192 
ministration 1170 1035 
Iron overload [l] 1086 + 53 1404 f 240 
Iron deficiency [2] 943 + 80 1380 f 150 
Relative rate of transferrin and albumin gene 
transcription was measured in isolated liver nuclei from 
animals under various hormonal conditions. For iron 
deficiency and iron overload, results are means f 1 SD 
of 6 different determinations performed in 3 animals (2 
per animal). For castration and influence of oestradiol, 
results are for single animals. The results are expressed 
in part per million (ppm) of specific transferrin mRNA 
3. RESULTS 
3.1. Iron deficiency and overload 
Fig.1 and table 1 show that no significant 
reproducible modification of transferrin mRNA 
content and gene transcription could be observed 
either in rats overloaded with iron or in anaemic, 
iron-deficient animals. 
3.2. Influence of sexual steroid hormones 
In the same way, fig.2 and table 1 indicate that 
transferrin gene expression was not affected by 
either oestrogens or testosterone. These results are 
in agreement with those obtained in two pregnant 
female rats (transferrin mRNA = 2180 and 
2300 cpm/pg RNA) and with those we have recent- 
ly published using pre- and post-pubescent males 
and females: indeed, transferrin mRNA concentra- 
tion in the rat liver is practically stable from birth 
to the middle of life [9]. 
3.3. Influence of glucagon and cyclic AMP 
In fig.3, it can be observed that, in contrast, 
treatment for 12 or 24 h with dibutyryl CAMP or 
glucagon resulted in a decrease of about 50% in 
i i 24 hours 
T : 
24 hours 
Fig.2. Influence of oestradiol and testosterone on liver 
transferrin mRNA content. (A) 1 mg testosterone was 
injected into castrated male rats at time zero. (B) 20pg 
oestradiol were injected into castrated female rats at 
time zero. Legend and symbols similar to fig. 1. 
= 
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Fig.3. Influence of dibutyryl cyclic AMP and glucagon 
on liver transferrin mRNA content. (1) Control. (2,3) 
12 h treatment. (2) CAMP, 0.2 mg/kg per h; (3) long- 
acting glucagon, 100 pg/12 h. (4-7) 24 h treatment. (4) 
0.2 mg/kg per h CAMP; (5) 0.5 mg/kg per h rapid 
glucagon; (6) long-acting glucagon, 200/g/24 h; (7) 
glucagon + insulin, 200 ,ug/24 h and 5 units regular and 
long-acting insulin, respectively. Each value represents 
the mean + SD of 6 determinations in each of 3 rats. 
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0 20min. 30min. 2H 12 H 
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Fig.4. Influence of glucagon and dibutyryl-cyclic AMP 
on the transcription rate of the transferrin gene. 
Glucagon (125pg/kg of body wt) was injected 
intravenously (animals) during 20 min, 30 min and 2 h. 
Long-acting glucagon was injected at the 12 h point [l]. 
Dibutyryl cyclic AMP (25 mg/kg of body wt) was 
injected intraperitoneally. (0) Glucagon, (A) dibutyryl 
cyclic AMP. Transferrin gene transcription was 
measured with the nuclear run-on transcription assay as 
indicated in section 2. Each individual value is expressed 
as a percentage of the mean transferrin gene 
transcription in untreated rats. 
transferrin mRNA; the effect of glucagon could 
not be reversed by insulin administered together 
with glucagon. 
The influence of glucagon and CAMP on the 
transcription rate of the transferrin gene is shown 
in fig.4. Glucagon infusion induced a rapid and 
specific inhibition of the transferrin gene transcrip- 
tion to less than 5% of the initial rate at the 30th 
min of treatment. Exactly the same result was ob- 
tained with dibutyryl CAMP. When glucagon infu- 
sion was prolonged for 2 h, a reinitiation of 
transferrin gene transcription could be observed; 
this result was confirmed in the animals treated 
with long-acting glucagon for 12 h. Such re- 
initiation of the transcription of genes negatively 
regulated by CAMP upon protracted treatment 
with glucagon cannot be explained by a desen- 
sitization of the hormone receptors because other 
genes, such as the pyruvate kinase gene, remain 
transcriptionally blocked under the same condi- 
tions [2]. 
Inhibition of gene transcription by CAMP is ob- 
viously neither a general phenomenon [4] nor an 
experimental artifact since the albumin gene 
transcription rate studied as a control under, the 
same conditions is not affected [2]. 
4. DISCUSSION 
Our results that sexual steroid hormones and 
iron status do not modulate transcription of the 
transferrin gene and specific RNA content are 
slightly at variance with the data of McKnight et 
al. [16,17] concerning regulation of the 
ovotransferrin gene in the chick liver: these 
authors reported transcription of the gene to be 
stimulated 1 S-2-fold by both iron deficiency and 
oestrogens. Chambon et al. [ 181, in contrast, were 
unable to confirm the regulation of this gene by 
oestrogens in the chick liver. In any case it appears 
that regulation of the transferrin concentration in 
the serum is a function of the iron status, which is 
a phenomenon known for a long time [19], and is 
not primarily transcriptional. 
In fact, the main finding concerning transferrin 
gene regulation in the rat is that CAMP induces an 
almost complete, but transient blockade of gene 
transcription. From a physiological point of view, 
it is doubtful whether this phenomenon plays any 
significant role because transcriptional inhibition, 
although profound (>95%), is brief compared 
with the half-life of mRNA and, above all, pro- 
teins [mRNA level is not significantly decreased 
3 h after cordycepin injection in the rat (S. 
Vaulont et al., unpublished)]; transferrin half-life 
is 7-12 days [20,21]. 
From a theoretical point of view, however, this 
observation could be important. It is more and 
more evident that CAMP is frequently involved as 
a regulator of gene transcription in eucaryotes, 
sometimes as a transcripotional activator (for in- 
stance, in the liver, for the phosphoenolpyruvate 
carboxykinase [4] and tyrosine aminotransferase 
[3] genes), and sometimes as a transcriptional in- 
hibitor, as we have recently demonstrated for 3 
carbohydrate-induced hepatic genes encoding L- 
type pyruvate kinase, aldolase B and an uniden- 
tified 5.4 kb mRNA species [2]. In these 3 genes 
transcriptionally inhibited by CAMP, the inhibi- 
tion persists as long as glucagon or CAMP are ad- 
ministered (Vaulont et al., in preparation). 
Moreover, endogenous secretion of glucagon in- 
duced, for instance, by a protein-rich diet, results 
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in a blockade of the above gene transcription 
which can persists several days or weeks and is 
reversible only when protein administration is 
discontinued and glucagon secretion decreases 
(Vaulont et al., unpublished). In contrast, a pro- 
longed protein diet does not decrease transferrin 
gene transcription at all (Vaulont et al., in 
preparation). 
151 
The mechanism of the transcriptional effects of 
CAMP remains absolutely unknown, the two 
generally proposed hypotheses being that of the 
binding of CAMP to an eucaryotic equivalent of 
the E. coli cap protein [22] and of the phosphoryla- 
tion of a transcriptionally active factor [23,24]. 
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With regard to this latter hypothesis, it could be 
suggested that phosphorylation of transcription 
factors leading to this inactivation involves several 
classes of genes, some of them being able to 
specifically escape this inhibition. The molecular 
basis of this specific escape remains as obscure as 
that of the primitive action of CAMP; a differential 
rate of dephosphorylation of those factors active 
on reversibly or irreversibly inhibited genes could 
be speculated. 
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In any case, these results emphasize the complex 
role of CAMP on eucaryotic gene expression. 
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